ATTACHMENT 5 - QUESTIONS AND RESPONSE.pdf
PDF 95 KB Posted
- Attached to
- National On-Site Drug Testing Laboratory
- Solicitation number
- USCA25R0183
- Issued by
-
Administrative Office of the U.S. Courts
About this file
This document is a Questions and Answers (Q&A) file for Solicitation Number USCA25R0183 for a National On-Site Drug Testing Laboratory contract. The document contains 10 questions and responses related to various technical and operational aspects of the solicitation, including equipment requirements, maintenance, assay specifications, and testing procedures. Key points include: the Administrative Office of the Courts (AOC) will not provide historical LIS data to the new vendor, requiring them to establish their own data systems; the vendor must provide all required assays in liquid, ready-to-use format, including a Ketamine assay; and laboratories will be responsible for testing urine samples collected outside the laboratory, with the vendor providing necessary equipment and supplies for testing at specified facilities across the contiguous United States, Alaska, Hawaii, Puerto Rico, Guam, and the Virgin Islands.
The Q&A clarifies several critical contract details, such as: the requirement for quality control procedures with 95% accuracy, the need for preventative maintenance twice per year (or as per manufacturer recommendations), and confirmation that offerors should submit a single solution with one pricing table. The document also specifies that the vendor must provide any additional water system supplies needed to make equipment operational and will be responsible for equipment and supplies at the listed facilities. Notably, the government denied a request for a 2-week solicitation extension and did not disclose details about the incumbent contractor, referring interested parties to Section L of the RFP for that information.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| USCA25R0183_0001 - National DRUG LAB RFP 4.30.pdf | ||
| Attachment 2 - Laboratory locations.xlsx | XLSX spreadsheet | |
| Attachment 1 - National Drug Lab Price Sheet.xlsx | XLSX spreadsheet | |
| Attachment 2 - Laboratory locations.xlsx | XLSX spreadsheet | |
| USCA25R0183 - National DRUG LAB RFP 4.23 FINAL.pdf | ||
| Attachment 4 - Equipment and Reagent Requirements.pdf | ||
| Attachment 1 - National Drug Lab Price Sheet.xlsx | XLSX spreadsheet | |
| Attachment 3 - Specs for DTR PACTS Interface.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Question # location Question Response
1 L.1 We request a 2-week extension. An extension is not granted.
2 C.6
Will the AOC be responsible to provide the current Vendors LIS data, the AOC's drug testing historical data for all sites, at no cost and in a useable format (a headered CSV, XML, XLS, or TXT file etc.) to the winning/new LIS vendor; and will that data come with ample time to convert the majority of records prior to each site's install/golive and the remainder available on or just before installation if so?
No, the AOC will not be providing LIS data to the new vendor. It is unnecessary for the new vendor to have the information, and the new vendor can establish the data in their new LIS program.
3 C.5.4
Quality Control – Can the language be changed for item i. For those tests being analyzed qualitatively, quality controls with drug Concentrations at 25% above the assay cutoffs and 25% below the assay cutoffs if the
QC is available, should produce correct results at least 95% of the time.
No, the language cannot be changed. This is not an optional requirement. QC is not optional.
GENERAL &
Volume II
Attachment 1
Can an offeror respond with two options based on different instrumentation, which will require 2 separate/different pricing tables in
Volume II?
No, the offeror shall provide one solution and one price sheet (Attachment 1).
5 C.5.5.1 Does not having an OEM Ketamine assay preclude an offeror from responding to this solicitation?
The offeror shall provide all assays included within the SOW. Ketamine is a requirement in the SOW and will be evaluated as such.
6 C.5.2.3.d
Maintenance and Response Times (d) stating offeror shall provide preventative maintenance at each site twice per year, is that based on instrument manufacturer recommendations? Could it be based on manufacturer specifications and recommendations regarding preventative maintenance requirements as some equipment only requires 1 preventative maintenance service per year?
The offeror shall provide prevantative maintenance as required in the SOW. See C.5.2.3.d
7 C.5.1 (General) For certain equipment not requiring a detached water-system/supply as it is self-contained, does an offeror have to arrange and include DI (de-ionized/distilled) water delivery costs in its submission?
Yes, If the offeror's water system requires any additional supplies (i.e. specific water, salt, etc.) to make the system operable, the offeror is responsible for providing said supplies and including all associated costs within its submission. See C.5.1.
USCA25R0183 - NATIONAL DRUG TESTING LAB QUESTIONS
Section C.5.5.a /
Attachment 4
Equipment & Reagent Requirements, how does an offeror represent that it is able to meet the cutoff requirements, but the reagent is lyophilized and requires reconstitution and equilibration (i.e., not liquid, ready to use)?
The offeror shall provide all assays in liquid, ready to use as required within the SOW. See Section
C.5.5.a
9 GENERAL We would like some clarification on how the urine tests will be conducted. Specifically, will the offeror be responsible for running samples and supplying the necessary equipment for each of the listed facilities, or will facilities be awarded to contractors based on their location?
The laboratories will be responsible for testing urine samples that have been collected outside of the laboratory. The offeror is not responsbile for providing any equipment related to the collection of the urine specimen. The offeror is responsible for providing all equipment and supplies, as outlined in the SOW, for testing of the urine samples. Refer to
Attachment 2 for locations of facilities where is offeror is required to provide equipment.
10 SECTION L
Is this activity considered a new requirement or a follow-on to an existing contract? If there is an incumbent, would you be able to share the vendor’s name, the contract number, value, award date and expiration date? Stated in Section L of the RFP.
File details come from the government source that posted it. Updated .